Nucleic Acid Isolation and Purification Market

The global nucleic acid isolation and purification (NAIP) market is valued at an estimated USD 6.37 billion in 2026 and is projected to reach USD 9.66 billion by 2031, at a CAGR of 8.7% during the forecast period. The growth of this market is mainly driven by rising adoption of automated nucleic acid extraction systems, increasing need for high-purity and inhibitor-free nucleic acid recovery, and growing awareness of the importance of DNA isolation and purification in different applications.

Key players in the industry include Thermo Fisher Scientific Inc. (US), Qiagen N.V. (Netherlands), F. Hoffmann-La Roche Ltd. (Switzerland), Merck KGaA (Germany), Danaher Corporation (US), Promega Corporation (US), Agilent Technologies, Inc. (US), Bio-rad Laboratories, Inc. (US), illumina, inc. (US), Takara Bio Inc. (Japan), New England Biolabs (US), A&A biotechnology (Poland), Revvity, Inc. (US), Bioneer Corporation (South Korea), HiMedia Laboratories Pvt. Ltd. (India), among others. Companies in this market are focusing on new product launches and approvals to strengthen their product portfolios and expand their presence in the nucleic acid isolation and purification market.

To know about the assumptions considered for the study download the pdf brochure

For instance, in September 2025, Thermo Fisher launched MagMAX HMW DNA Kit for high molecular weight DNA extraction, focused on long-read sequencing applications and automated KingFisher workflows.

In October 2025, QIAGEN announced its 4,000th QIAcube Connect placement and said cumulative QIAcube family placements had reached nearly 13,000. It also reiterated upcoming launches of QIAsymphony Connect, QIAsprint, and QIAmini.

In October 2025, Merck launched the MagPrep Viral RNA Isolation Kit and MagPrep cfDNA Isolation Kit. The cfDNA kit is for the isolation of cell-free DNA from blood for liquid biopsy, while the viral RNA kit is for the isolation of viral RNA from biological samples such as nasal swabs.

Thermo Fisher Scientific Inc. (US)

Thermo Fisher holds a dominant leadership position in the NAIP market due to its end-to-end ecosystem approach, combining extraction kits, magnetic bead chemistries, KingFisher automation platforms, and strong integration with PCR, qPCR, and NGS workflows. Its scale, global reach, and deep penetration across clinical, research, and biopharma segments allow it to influence market direction, particularly in high-throughput automation and standardized workflows, making it the most strategically influential player in the NAIP space.

QIAGEN N.V. (Netherlands)

QIAGEN maintains a strong leadership position as a specialist and innovation-driven player in sample technologies, with a focused portfolio across nucleic acid extraction kits, automation platforms, and application-specific workflows such as liquid biopsy, FFPE, and microbiome. Its dominance is driven by deep expertise in sample preparation, strong brand recognition, and high customer loyalty, positioning it as a key reference player in both research and clinical NAIP workflows.

Merck KGaA (Germany)

Merck KGaA holds a leading position as a critical upstream enabler in the NAIP market, with strong capabilities in reagents, membranes, and consumable inputs used across extraction workflows. While it is less dominant in integrated systems, its strength lies in being a foundational supplier to a wide range of NAIP applications, particularly in research and biopharma, giving it significant influence across the broader value chain and ensuring a stable and strategic role in the market.

Market Ranking

The global nucleic acid isolation and purification market is highly competitive, with many companies providing advanced isolation and purification technologies, consumables, and instruments. Key players such as Thermo Fisher Scientific, QIAGEN, Merck, Roche, and Danaher Corporation dominate the market with their validated kits, isolation systems, purification platforms, and reagents used in diagnostics, drug discovery and development, personalized medicine, and other applications.

These companies supply critical tools that enable clinical laboratories, research institutes, biopharma companies, and CROs to obtain high-quality DNA/RNA for downstream PCR, qPCR, NGS, liquid biopsy, and other molecular workflows. Major players continue to invest in automated extraction platforms, magnetic bead-based chemistries, application-specific kits, and digitally connected sample preparation systems to improve throughput, reproducibility, contamination control, and workflow efficiency across global markets.

Related Reports:

Nucleic Acid Isolation and Purification Market by Product (Kits, Reagents, Instruments), Method (Column, Magnetic Beads), Type (Plasmid DNA, microRNA), Sample Type (Cellular, FFPE, CfDNA/CtDNA), Application, End User, Competition - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]